Neha Bhasin Hoer, MD

I am a Pediatric Hematologist/Oncologist with subspecialty interest in Pediatric Hematology. I am the Medical Director for the Pediatric Sickle Cell Program in Oakland. My clinical interests include Sickle Cell Disease, Bleeding, Thrombosis, Iron Deficiency anemia and other Cytopenias. My research focuses on the needs of my patients specifically women's health, coagulopathy in sickle cell disease and acute chest syndrome.
Education
06/2014 - Certificate in Clinical and Translational Research, University of Iowa
06/2013 - Fellowship, Pediatric Hematology/Oncology, University of Iowa
06/2010 - Residency, Pediatrics, Stony Brook University Medical Center
MD, 06/2007 - Medicine, Ross University

  1. Treadwell MJ, Du L, Bhasin N, Marsh AM, Wun T, Bender MA, Wong TE, Crook N, Chung JH, Norman S, Camilo N, Cavazos J, Nugent D. Barriers to hydroxyurea use from the perspectives of providers, individuals with sickle cell disease, and families: Report from a U.S. regional collaborative. Frontiers in genetics 2022. PMID: 36092883


  2. Bhasin N, Roe DJ, Saboda K, Journeycake J, Moreno V, Lentz SR. Association of low serum albumin with venous thrombosis in pediatric patients. Thrombosis research 2022. PMID: 35988444



  3. Cabana MD, Marsh A, Treadwell MJ, Stemmler P, Rowland M, Bender MA, Bhasin N, Chung JH, Hassell K, Abdul Rashid NFN, Wong TE, Bardach NS. Improving Preventive Care for Children With Sickle Cell Anemia: A Quality Improvement Initiative. Pediatric quality & safety 2020. PMID: 33409431



  4. Niki M, Nayak MK, Jin H, Bhasin N, Plow EF, Pandolfi PP, Rothman PB, Chauhan AK, Lentz SR. Dok-1 negatively regulates platelet integrin αIIbβ3 outside-in signalling and inhibits thrombosis in mice. 2016. PMID: 26790499